Position in RXRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,051,243
-$440,378 QoQ
Shares Held
342,425
-6.1% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. RXRX ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,051,243 | 342,425 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,491,621 | 364,700 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,725,605 | 353,608 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,592,811 | 314,785 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,311,823 | 247,982 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,713,158 | 253,426 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,222,266 | 185,473 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,358,572 | 181,143 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,512,837 | 151,739 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,278,062 | 129,621 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $903,081 | 118,050 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $833,539 | 111,585 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $670,667 | 100,550 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $724,508 | 93,970 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $952,354 | 89,507 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $914,423 | 112,337 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $463,165 | 64,688 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $355,497 | 20,753 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $62,265 | 2,706 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $74,861 | 2,051 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||